BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260514T224138
CREATED:20181109T151157Z
LAST-MODIFIED:20181126T130220Z
UID:18365-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:ePharma IMPACT
DESCRIPTION:ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative\, next generation omni-channel strategies. \nThe 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact. \nHow do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships\, and greater influence over impactful marketing strategy. \nThe 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.
URL:https://www.pharmajournalist.com/event/epharma-impact/
LOCATION:NY Hilton 1335 Ave of the Americas New York\, NY 10017\, NY\, United States
ORGANIZER;CN="Knect365":MAILTO:register@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260514T224138
CREATED:20190219T121841Z
LAST-MODIFIED:20190219T121841Z
UID:19638-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:Innate Killer Summit 2019
DESCRIPTION:Accelerate to Market Genetically Engineered\, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications \n The Innate Killer Summit 2019 discusses safer\, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy. \n \nIt will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability. \nBringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.
URL:https://www.pharmajournalist.com/event/innate-killer-summit-2019/
LOCATION:Hilton San Diego Gaslamp Quarter\, 401 K St\, San Diego\, CA 92101
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR